文献速递神经肿瘤

按2016 CNS肿瘤WHO分类鉴定患者来源的原代胶质瘤细胞系并与亲本肿瘤比较

Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours.
PubMed 文献 · J Neurooncol · 2021-01-04

研究建立了12株患者胶质瘤来源的原代细胞系,按2016 CNS肿瘤WHO分类进行免疫组化和分子特征鉴定,并比较细胞系与亲本组织的胶质瘤标志物和MGMT启动子甲基化状态。结果显示培养细胞保持与亲本组织相同的特征,支持细胞系作为胶质瘤研究和药物发现的模型。

要点

  • 12株胶质瘤原代细胞系涵盖胶质母细胞瘤、III级和低级别胶质瘤。
  • 细胞系经VIMENTIN、GFAP、IDH1R132、ATRX免疫组化和MGMT启动子甲基化鉴定。
  • 细胞系与亲本组织免疫组化和MGMT甲基化特征一致。

核心结论

  • 患者来源的胶质瘤原代细胞系经2016 CNS肿瘤WHO分类鉴定后,保持与亲本肿瘤相同的免疫组化和MGMT启动子甲基化特征。

研究设计与样本

  • 研究建立12株患者胶质瘤来源的原代细胞系,按2016 CNS肿瘤WHO分类进行免疫组化和分子特征鉴定,并与亲本肿瘤组织比较。

主要发现

  • 12株细胞系中8株为胶质母细胞瘤细胞,2株为III级胶质瘤细胞(间变性星形细胞瘤和少突星形细胞瘤),2株为低级别胶质瘤细胞(II级星形细胞瘤和少突胶质细胞瘤)。
  • 所有细胞系经免疫组化分析VIMENTIN、GFAP、IDH1R132和ATRX,并检测MGMT基因启动子甲基化状态。
  • 细胞系与亲本组织的免疫组化特征和MGMT甲基化状态比较显示,培养细胞保持相同特征。

临床怎么用

  • 患者来源的原代胶质瘤细胞系可作为研究肿瘤生物学和药物发现的实验模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gliomas represent about 80% of primary brain tumours and about 30% of malignant ones, which today don't have a resolution therapy because of their variability. A valid model for the study of new personalized therapies can be represented by primary cultures from patient's tumour biopsies. METHODS: In this study we consider 12 novel cell lines established from patients' gliomas and immunohistochemically and molecularly characterized according to the newly updated 2016 CNS Tumour WHO classification. RESULTS: Eight of these lines were glioblastoma cells, two grade III glioma cells (anaplastic astrocytoma and oligo astrocytoma) and two low grade glioma cells (grade II astrocytoma and oligodendroglioma). All cell lines were analysed by immunohistochemistry for specific glioma markers, respectively VIMENTIN, GFAP, IDH1R132, and ATRX. The methylation status of the MGMT gene promoter was also determined in all lines. The comparison of the immunohistochemical characteristics and of the MGMT methylation status of the lines with the tissues of origin shows that the cells in culture maintain the same characteristics. CONCLUSIONS: Human cancer cell lines represent a support in the knowledge of tumour biology and in drug discovery through its facile experimental manipulation. TRIAL REGISTRATION: NCT04180046.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Oliva MA, Staffieri S, Castaldo S, et al. Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours. J Neurooncol. 2021. PMID: 33398536. doi:10.1007/s11060-020-03673-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。